MK

Mithilesh Kumar

Active Director Director DIN 10183744
DIN 10183744 First appointment May 2023 Primary industry Oil & Gas
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Mithilesh Kumar

Data last updated:

Mithilesh Kumar is a Director at Luxem Pharmaceuticals Private Limited (since 2023). The company operates in Oil & Gas. Luxem Pharmaceuticals Private Limited reported revenue of ₹3.66 Cr (FY 2025).

DIN 10183744
Primary Designation Director
Industry Oil & Gas
First Appointment 30 May 2023
Oldest Company Age 3 yrs
Largest company Luxem Pharmaceuticals Private Limited · ₹3.66 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20232023₹3.66 Cr (FY 2025)Active

Board colleagues of Mithilesh Kumar

NameDINCompanyDesignation
Neha Kumari10183745Luxem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Luxem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mithilesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithilesh Kumar

Mithilesh Kumar currently holds 1 directorship: Luxem Pharmaceuticals Private Limited (Director, since 30 May 2023, revenue ₹3.66 Cr (FY 2025)).

Mithilesh Kumar was first appointed on 30 May 2023 as Director at Luxem Pharmaceuticals Private Limited.

The current boards of Mithilesh Kumar's companies include Neha Kumari (Luxem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available